| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: Departments of 1 Cancer Biology, 2 Breast Medical Oncology, 3 Bioistatistics, and 4 Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Aysegul A. Sahin, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 85, Houston TX 77030. Phone: 713-794-1500; Fax: 713-745-5709; E-mail: asahin{at}mdanderson.org.
Purpose: The chemokine receptors CCR7 and CXCR4 have been shown to play an important role in cancer metastasis. We therefore studied the differential expression of CCR7 and CXCR4, along with that of the biomarker HER2-neu, to evaluate whether these biomarkers could predict axillary lymph node metastasis in breast cancer.
Experimental Design: Biomarker expression levels were evaluated using paraffin-embedded tissue sections of lymph node–negative (n = 99) and lymph node–positive (n = 98) T1 breast cancer by immunohistochemical staining.
Results: Lymph node–positive tumors showed higher rates of high cytoplasmic CCR7 staining (21.5% versus 8.5%, P = 0.013) and HER2-neu overexpression (21.5% versus 9.3%, P = 0.019) than did lymph node–negative tumors. Similarly, high cytoplasmic CXCR4 expression occurred more commonly in lymph node–positive tumors (11.2% versus 5.1%, P = 0.113). In contrast, predominantly nuclear CXCR4 staining was more likely to be found in lymph node–negative tumors (54.5% versus 37.8%, P = 0.018). Furthermore, cytoplasmic CXCR4 coexpressed with HER2-neu was the only factor associated with involvement of four or more lymph nodes (16.7% versus 1.2%, P = 0.04) among lymph node–positive tumors. When all three biomarkers (CCR7, CXCR4, HER2-neu) were utilized together, 50.0% of lymph node–positive tumors highly expressed one of these biomarkers compared with 18.8% of the lymph node–negative tumors (P < 0.0001).
Conclusions: Our results suggest that the chemokine receptor CCR7 is a novel biomarker that can predict lymph node metastases in breast cancer. Utilization of additional markers, such as CXCR4 and HER2-neu, further improves the prediction of the presence and extent of lymph node involvement.
This article has been cited by other articles:
|
|
 |
|
  M. G. ACHEN and S. A. STACKER Molecular Control of Lymphatic Metastasis Ann. N.Y. Acad. Sci., May 1, 2008; 1131(1): 225 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-R. Pan, M.-F. Hou, H.-C. Chang, and W.-C. Hung Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells J. Biol. Chem., April 25, 2008; 283(17): 11155 - 11163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ziegler, M. Oberbarnscheidt, S. Bulfone-Paus, R. Forster, U. Kunzendorf, and S. Krautwald CCR7 Signaling Inhibits T Cell Proliferation J. Immunol., November 15, 2007; 179(10): 6485 - 6493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Baatar, P. Olkhanud, D. Newton, K. Sumitomo, and A. Biragyn CCR4-Expressing T Cell Tumors Can Be Specifically Controlled via Delivery of Toxins to Chemokine Receptors J. Immunol., August 1, 2007; 179(3): 1996 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Cabioglu, Y Gong, R Islam, K. Broglio, N Sneige, A Sahin, A. Gonzalez-Angulo, P Morandi, C Bucana, G. Hortobagyi, et al. Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer Ann. Onc., June 1, 2007; 18(6): 1021 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Harvey, P. Mellor, H. Eldaly, T. W.J. Lennard, J. A. Kirby, and S. Ali Inhibition of CXCR4-Mediated Breast Cancer Metastasis: A Potential Role for Heparinoids? Clin. Cancer Res., March 1, 2007; 13(5): 1562 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tsoli, P. K Tsantoulis, A. Papalambros, B. Perunovic, D. England, D. A Rawlands, G. M Reynolds, D. Vlachodimitropoulos, S. L Morgan, C. A Spiliopoulou, et al. Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer J. Clin. Pathol., March 1, 2007; 60(3): 261 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Kodama, Hasengaowa, T Kusumoto, N Seki, T Matsuo, Y Ojima, K Nakamura, A Hongo, and Y Hiramatsu Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer Ann. Onc., January 1, 2007; 18(1): 70 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wilson, J. Burchell, and M. J. Grimshaw Endothelins Induce CCR7 Expression by Breast Tumor Cells via Endothelin Receptor A and Hypoxia-Inducible Factor-1 Cancer Res., December 15, 2006; 66(24): 11802 - 11807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Andre, N. Cabioglu, H. Assi, J. C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J. P. Spano, C. Combadiere, C. Bucana, et al. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer Ann. Onc., June 1, 2006; 17(6): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ghadjar, S. E. Coupland, I.-K. Na, M. Noutsias, A. Letsch, A. Stroux, S. Bauer, H. J. Buhr, E. Thiel, C. Scheibenbogen, et al. Chemokine Receptor CCR6 Expression Level and Liver Metastases in Colorectal Cancer J. Clin. Oncol., April 20, 2006; 24(12): 1910 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kakinuma and S. T. Hwang Chemokines, chemokine receptors, and cancer metastasis J. Leukoc. Biol., April 1, 2006; 79(4): 639 - 651. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
